0001209191-22-037017.txt : 20220615 0001209191-22-037017.hdr.sgml : 20220615 20220615170025 ACCESSION NUMBER: 0001209191-22-037017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220613 FILED AS OF DATE: 20220615 DATE AS OF CHANGE: 20220615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smaldone Alsup Laurie CENTRAL INDEX KEY: 0001589602 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39743 FILM NUMBER: 221018398 MAIL ADDRESS: STREET 1: 190 WOOSAMONSA RD CITY: PENNINGTON STATE: NJ ZIP: 08534 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kinnate Biopharma Inc. CENTRAL INDEX KEY: 0001797768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824566526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8582994699 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-13 0 0001797768 Kinnate Biopharma Inc. KNTE 0001589602 Smaldone Alsup Laurie 103 MONTGOMERY STREET, SUITE 150 THE PRESIDIO OF SAN FRANCISCO SAN FRANCISCO CA 94129 1 0 0 0 Stock Option (right to buy) 8.38 2022-06-13 4 A 0 20250 0.00 A 2032-06-13 Common Stock 20250 20250 D 1/12th of the shares underlying the Option vest and become exercisable on a monthly basis starting July 13, 2022 (the Vest Base Date) and thereafter on the same day of the month as the Vest Base Date or if earlier, the day immediately before the date of the next Annual Meeting of Stockholders that occurs after the Vest Base Date. /s/ Mark A. Meltz, as attorney-in-fact 2022-06-15